Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about AXSM
Recent news which mentions AXSM
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
8 Analysts Have This to Say About Axsome Therapeutics
September 30, 2022
Tickers
AXSM
Tags
Market News
Analyst Ratings
Benzinga
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
Tickers
ABBV
APLS
AXSM
BIIB
Tags
ABBV
BZI/AUOA
Benzinga
From
Benzinga
2 No-Brainer Biotech Stocks to Buy Right Now
September 26, 2022
Tickers
AXSM
EXEL
Tags
Recent Press Releases
Market News
AXSM
From
Motley Fool
3 Monster Stocks in the Making
September 24, 2022
Tickers
AXSM
EXEL
TWST
Tags
Recent Press Releases
Market News
EXEL
From
Motley Fool
If You Invested $10,000 in Axsome Therapeutics 5 Years Ago, This Is How Much You Would Have Today
September 23, 2022
Tickers
AXSM
JAZZ
Tags
AXSM
JAZZ
Market News
From
Motley Fool
2 Reasons to Buy Axsome Therapeutics, and 1 Reason to Sell
September 22, 2022
Tickers
AXSM
JAZZ
Tags
AXSM
Recent Press Releases
Market News
From
Motley Fool
2 Biotech Stocks That Could Make You Richer
September 17, 2022
Tickers
AXSM
CRSP
Tags
CRSP
AXSM
Recent Press Releases
From
Motley Fool
Is It Too Late to Buy Axsome Therapeutics Stock?
September 17, 2022
Tickers
AXSM
JAZZ
Tags
AXSM
Recent Press Releases
Market News
From
Motley Fool
7 Top-Rated Biotech Stocks to Buy for Q4
September 15, 2022
Tickers
ABBV
ABT
ADMA
AXSM
Tags
VYGR
GERN
ABBV
From
InvestorPlace
3 Top Healthcare Stocks Defying the Bear Market
September 15, 2022
Tickers
AXSM
MCK
VRTX
Tags
AXSM
MCK
VRTX
From
Motley Fool
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
September 12, 2022
Tickers
AXSM
BBY
BIIB
LLY
Tags
NYSEARCA:XBI,NYSE:BBY,NYSE:LLY,NASDAQ:BIIB,NASDAQ:VRTX,NASDAQ:AXSM
XBI
AXSM
From
InvestorPlace
3 Growth Stocks That Are Crushing It This Year
September 10, 2022
Tickers
AXSM
NBIX
VRTX
Tags
AXSM
NBIX
VRTX
From
Motley Fool
2 Top Biotech Stocks Defying the Bear Market
September 10, 2022
Tickers
AXSM
CORT
Tags
Recent Press Releases
CORT
Market News
From
Motley Fool
Is Axsome Therapeutics a Buy?
September 09, 2022
Tickers
AXSM
JAZZ
Tags
Market News
Recent Press Releases
JAZZ
From
Motley Fool
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
Tickers
ALNY
AMYT
AXSM
LLY
Tags
Biotech
Biotech Catalysts / EOD Summary
General
From
Benzinga
Mizuho Bolsters Price Target By 55% On This Migraine Stock
September 07, 2022
Tickers
AXSM
Tags
Analyst Ratings
Analyst Color
Biotech
From
Benzinga
Nasdaq Bear Market: 2 Top Growth Stocks You'll Wish You'd Bought on the Dip
September 05, 2022
Tickers
AXSM
UPST
Tags
UPST
Market News
Recent Press Releases
From
Motley Fool
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
Tickers
AXSM
BNTX
HLTH
HOWL
Tags
FDA
YMAB
News
From
Benzinga
Axsome Therapeutics Commences Late-Stage Migraine Study
September 01, 2022
Tickers
AXSM
Tags
Health Care
Patient Enrollment
Benzinga
From
Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
Tickers
ACAD
AMGN
AMLX
AXSM
Tags
FOLD
Penny Stocks
CRMD
From
Benzinga
Analyst Ratings for Axsome Therapeutics
August 30, 2022
Tickers
AXSM
Tags
AXSM
BZI/AAR
Benzinga
From
Benzinga
Expert Ratings for Axsome Therapeutics
August 30, 2022
Tickers
AXSM
Tags
Market News
Analyst Ratings
Benzinga
From
Benzinga
HC Wainwright Boosts Price Target On This Stock By 167%, Plus B of A Securities Predicts $40 For This Online Travel Stock
August 30, 2022
Tickers
ANF
AXSM
COUP
CTLT
Tags
CTLT
Markets
AXSM
From
Benzinga
The Bull Market Is Still Alive
August 29, 2022
Tickers
AMSC
AXSM
BEEM
BLNK
Tags
RCEL
TWLO
VCEL
From
InvestorPlace
The Bull Market Is Still Alive
August 29, 2022
Tickers
AMSC
AXSM
BEEM
BLNK
Tags
CVX
AXSM
FNGR
From
InvestorPlace
$1000 Invested In Axsome Therapeutics 5 Years Ago Would Be Worth This Much Today
August 29, 2022
Tickers
AXSM
Tags
AXSM
Market News
BZI/POD
From
Benzinga
A Golden Ticket to Beat the Fed and Profit in “Hidden Bull Markets”
August 29, 2022
Tickers
AMSC
AXSM
BEEM
BLNK
Tags
BLNK
EVER
PLUG
From
InvestorPlace
3 Healthcare Stocks That Are Beating the Market
August 28, 2022
Tickers
AXSM
RYTM
SWAV
Tags
RYTM
SWAV
AXSM
From
Motley Fool
3 Growth Stocks Poised to Skyrocket
August 27, 2022
Tickers
AXSM
CRSP
MRNA
NVAX
Tags
Recent Press Releases
PFE
MRNA
From
Motley Fool
This Growth Stock Is Soaring. Is It a Buy?
August 26, 2022
Tickers
AXSM
Tags
AXSM
Recent Press Releases
Market News
From
Motley Fool
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today